Commentary|Podcasts|November 18, 2025

Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition

This week, host Craig Beavers spoke with Joe Sassine, PharmD, BCPS, BCACP, CLS, about several key trials presented at the American Heart Association 2025 Scientific Sessions.

Show notes:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME